Detected ·
Nanopath
$25MSeries B
Nanopath, a Dartmouth-founded diagnostics startup building rapid point-of-care molecular tests for vaginitis, raised $25M in Series B led by Norwest and Medtech Convergence Fund.
- Website
- —
- linkedin.com/company/64856154
- Amount
- $25 000 000 USD
- Stage
- Series B
- Event
- Funding round
- Detected
- 2026-11-11 08:07:12 UTC
- Signal ID
- dabf2e0d-3d34-4d37-9af4-5e075272312e
As the API returns it
{
"id": "dabf2e0d-3d34-4d37-9af4-5e075272312e",
"created_at": "2026-11-11T08:07:12.863029Z",
"company_name": "Nanopath",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/64856154",
"event_type": "funding",
"funding_amount": 25000000,
"funding_currency": "USD",
"funding_stage": "series_b",
"message": "*Nanopath, a Dartmouth-founded diagnostics startup building rapid point-of-care molecular tests for vaginitis, raised $25M in Series B led by Norwest and Medtech Convergence Fund.*"
}